跳至主要内容
临床试验/NCT02041286
NCT02041286已完成不适用

User Performance of the Karajishi Contour Blood Glucose Monitoring System

Ascensia Diabetes Care2 个研究点 分布在 1 个国家目标入组 136 人开始时间: 2014年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
136
试验地点
2
主要终点
Number of Self-Test Fingerstick Blood Glucose (BG) Results Within +/- 15 mg/dL (<100 mg/dL) and Within +/- 15% (>=100 mg/dL) of Laboratory Glucose Method

研究概览

简要总结

The purpose of this study is to determine if subjects who have diabetes can operate the Investigational Blood Glucose Monitoring System (BGMS) without training and obtain valid glucose results.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Males and females, 18 years of age and older
  • •People with type 1 or type 2 diabetes
  • •Able to speak, read, and understand English
  • •Willing to complete all study procedures

排除标准

  • •Hemophilia or any other bleeding disorder
  • •Pregnancy
  • •Physical, visual, or neurological impairments that would make the person unable to perform testing with the BGM
  • •Previously participated in a BG monitor study using the Karajishi BGMS (or used a Bayer Contour meter)
  • •Working for a medical laboratory, hospital, or other clinical setting that involves training on and clinical use of blood glucose monitors
  • •Working for a competitive medical device company, or having an immediate family member who works for such a company
  • •A condition which, in the opinion of the investigator or designee, would put the person or study conduct at risk

研究组 & 干预措施

Intended Users of the Monitoring System

Experimental

Subjects with diabetes use the Karajishi Contour Investigational BG Monitoring System with no training. The criteria for the intended use population:

  1. At least 60% of subjects will be younger than age 65
  2. At least 10% of subjects will have type 1 diabetes

干预措施: Karajishi Contour Investigational BG Monitoring System (Device)

结局指标

主要结局

Number of Self-Test Fingerstick Blood Glucose (BG) Results Within +/- 15 mg/dL (<100 mg/dL) and Within +/- 15% (>=100 mg/dL) of Laboratory Glucose Method

时间窗: 1 hour

Subjects with diabetes self-test fingerstick blood use an investigational Blood Glucose Monitoring System (BGMS) with no training. BGMS results are compared with subject capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI Analyzer BG results are used to calculate the number of BGMS results within +/-15 mg/dL (\<100 mg/dL YSI capillary plasma) and +/-15% (\>=100 mg/dL YSI capillary plasma).

次要结局

  • Number of Venous Blood Glucose (BG) Results Within +/- 15 mg/dL (<100 mg/dL) and Within +/- 15% (>=100 mg/dL) of Laboratory Glucose Method(1 hour)
  • Number of Blood Glucose (BG) Results From Alternative Site Testing (AST) Palm Blood Within +/- 15 mg/dL (<100 mg/dL) and Within +/- 15% (>=100 mg/dL) of Laboratory Glucose Method(1 hour)
  • Number of Subject Fingerstick Blood Glucose (BG) Results Within +/- 15 mg/dL (<100 mg/dL) and Within +/- 15% (>=100 mg/dL) of Laboratory Glucose Method When Obtained and Tested by Study Staff(1 hour)
  • Number of Subject Responses That Strongly Agree or Agree or Are Neutral With Questionnaire Statements(1 hour)

研究者

发起方
Ascensia Diabetes Care
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Evaluation of an Karajishi Contour Investigational... | 临床试验